Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

4 Mar 2011 09:13

RNS Number : 3465C
e-Therapeutics plc
04 March 2011
 



e-Therapeutics plc("e-Therapeutics" or the "Company")

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

The Company was informed on the 3 March 2011 that Steve Self, an Executive Director, purchased on the 3 March 2011 50,000 ordinary shares at 36.5p per share. His resultant total holding is 86,413 shares representing 0.12% of the issued share capital of the company.

 

4 March 2011.

 

For more information, please contact:

 

e-Therapeutics plc

Malcolm Young / John Cordiner

Tel: +44 (0) 191 233 1317

E-mail: malcolm@etherapeutics.co.uk

www.etherapeutics.co.uk

 

Panmure Gordon (UK) Limited

Andrew Burnett / Aubrey Powell

Tel: +44 (0) 20 7459 3600

www.panmuregordon.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIFLAVVISIIL

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS